Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
Womens Health (Lond). 2023 Jan-Dec;19:17455057231172355. doi: 10.1177/17455057231172355.
Although recommended for all member states of World Health Organization, there is no national human papillomavirus vaccination program in Kazakhstan. Furthermore, there are no studies in Kazakhstan that evaluate the mothers' perception of human papillomavirus vaccines.
This study aims to assess the knowledge and attitudes toward human papillomavirus vaccination among mothers in Kazakhstan and the factors associated with their attitudes.
A cross-sectional study was performed during the period of December 2021-February 2022. The STROBE guideline for cross-sectional studies was applied.
Paper-based structured questionnaires were filled out by 191 mothers, 141 of whom had daughters. The attitude score was assessed as per the Likert-type scale. The Chi-square and Fisher's exact tests, with a significance value of < 0.05 were used to analyze the relationships between the characteristics of mothers and their attitude scores.
The following factors were significantly associated with mothers' attitudes toward human papillomavirus vaccination: a place of residence, family income, number of children, and refusal of vaccination for themselves (p < 0.005). Of all participants, only 45% of all mothers, 41% of mothers with a female, and 46% of mothers with male children had positive attitudes toward human papillomavirus vaccination. The child's gender was not a significant determinant. Overall, the level of knowledge about human papillomavirus vaccination was found to be low. The median total score is 0 out of 12 for women who have negative and neutral attitudes toward human papillomavirus vaccines. Among women who have positive attitudes toward HPV vaccines, the median score is around 3 points.
Before the implementation of the human papillomavirus vaccination program into the Kazakhstani national vaccination calendar, comprehensive and adequate information and education campaigns are required on the national level for parents and the population in general.
尽管世界卫生组织建议所有成员国实施,但哈萨克斯坦尚未制定国家人乳头瘤病毒疫苗接种计划。此外,哈萨克斯坦尚无评估母亲对人乳头瘤病毒疫苗看法的研究。
本研究旨在评估哈萨克斯坦母亲对人乳头瘤病毒疫苗的知识和态度,以及与其态度相关的因素。
本研究为 2021 年 12 月至 2022 年 2 月期间进行的横断面研究。采用 STROBE 横断面研究指南。
191 名母亲填写了纸质结构问卷,其中 141 名母亲的女儿在接种疫苗范围内。根据李克特量表评估态度评分。使用卡方检验和 Fisher 确切检验(显著性值<0.05)分析母亲特征与态度评分之间的关系。
以下因素与母亲对人乳头瘤病毒疫苗接种的态度显著相关:居住地、家庭收入、子女数量和拒绝为自己接种疫苗(p<0.005)。在所有参与者中,仅有 45%的母亲、41%有女儿的母亲和 46%有儿子的母亲对人乳头瘤病毒疫苗接种持积极态度。儿童的性别不是一个显著的决定因素。总体而言,人乳头瘤病毒疫苗接种知识水平较低。对人乳头瘤病毒疫苗持否定和中性态度的母亲总分为 0 分(满分 12 分)。对 HPV 疫苗持积极态度的母亲中,中位数评分为 3 分左右。
在将人乳头瘤病毒疫苗接种计划纳入哈萨克斯坦国家免疫接种日程之前,需要在国家层面上针对父母和公众开展全面和充分的信息和教育活动。